Loading decisions…
Loading decisions…
2,396 vetted Board decisions for Sarcoidosis.
The Veteran's appeal for service connection for sarcoidosis has been dismissed due to procedural issues. The appeals for service connection for lupus and asthma are remanded.
The Veteran's service-connected sarcoidosis is granted on a presumptive basis under the PACT Act. The Veteran's bilateral hearing loss and keratoconus are denied for increased ratings.
The Board has remanded the Veteran's claim of service connection for a respiratory disorder, to include pulmonary sarcoidosis, due to insufficient evidence and failure to consider certain records. The Veteran is presumed to have incurred his current respiratory disorder during service.
The Board has remanded the cases for further development and examination as they are not adequately addressed in the current record.
The Board has determined that the Veteran's service-connected disabilities alone have rendered him unable to secure or follow a substantially gainful occupation, and thus grants his claim for TDIU.
The Board has granted service connection for the cause of the Veteran's death, finding that his transverse myelitis with sarcoidosis was related to his military service or a service-connected disability and ultimately resulted in his death. The Board resolved all reasonable doubt in favor of the appellant.
The Veteran's sarcoidosis has been granted service connection, with the Board finding reasonable doubt in favor of a link to active service.,His bilateral eye disability is also granted as secondary to his now service-connected sarcoidosis.
The Board denied the Veteran's claim for service connection for sarcoidosis, finding that there was no evidence of chronic disease in service or within a presumptive period. The disability was not shown to be related to an in-service injury or event.
The Veteran's appeal for a higher rating for his service-connected sarcoidosis has been dismissed due to the death of the Veteran.
The Veteran's claim for a higher disability rating for service-connected sarcoidosis was initially granted in March 2020, but the RO denied an increased rating. The Veteran requested HLR multiple times and submitted additional evidence. A new VA examination is needed to reassess the severity of his sarcoidosis.
The Board has determined that the Veteran's complete STRs are incomplete and remands the case for obtaining these records. The Veteran is diagnosed with sarcoidosis, which may be related to service based on her treatment history during active duty.
The Veteran's claim for a higher rating for sarcoidosis with liver involvement, claimed as lung condition, is being remanded due to the need for an examination to assess the impact of the liver involvement on his overall disability picture.
Service connection for sarcoidosis with interstitial lung disease is granted as of August 10, 2022, under the PACT Act. The issue of service connection prior to this date remains remanded.
The Veteran's service-connected disabilities require him to have regular aid and attendance of another person, leading to the grant of special monthly compensation based on this need.
The Board remands the claim for service connection for a pulmonary disability, claimed as sarcoidosis, to obtain additional evidence and ensure compliance with previous remand directives.
The Board has remanded the Veteran's claims for sarcoidosis of the lungs, eye disabilities, and depression with anxious features due to incomplete development and duty-to-assist errors. The issues are inextricably intertwined.
The Board dismissed the appeal as it was a proposed reduction in disability rating, not an actual final decision. The Veteran's disability rating for asthma with sarcoidosis remains at 60%.
The Veteran's claim for a higher rating for sarcoidosis prior to February 2, 2022 is being remanded due to the need for clarification on whether the prescribed medication (Budesonide 80/Formoterol 4.5MCG) constitutes a low dose or high dose corticosteroid.
The Veteran's claim for service connection for sarcoidosis is granted, and the effective date is set at February 19, 2016.
The Board has determined that the claims for service connection for sarcoidosis and pulmonary embolisms must be remanded due to a lack of sufficient medical evidence. The VA will obtain a TERA-compliant medical opinion to assess whether these conditions are related to the Veteran's active-duty service, including his exposure to herbicide agents from his service in the Republic of Vietnam.
← Back to Sarcoidosis overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.